The revisions to the MDS include structural data redesign, standardized patient assessment elements, social determinants of health, and additional focus on reducing preventable hospitalizations. The session will provide strategies to operationalize the changes and review the changes to the Five Star Rating Program, Quality Reporting Program, Quality Measures, Value Based Purchasing and the implications if an expansion of the quality reporting program requires MDS submission for all SNF patients regardless of payer. Upon completion of this session, participants should be able to: • Discuss the impact of the RAI process on the standards of participation • Review the MDS item changes that will affect the Quality Reporting Program • Identify the changes to the Five Star Rating Program • Review the impact of the final rule for fiscal year 2024